Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2012
12/12/2012CN102816101A Synthesis method of (S)-N-methyl-2 chloro-ethyl-pyrrolidine
12/12/2012CN102816081A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
12/12/2012CN102099397B A method of synthesizing a substantially monodispersed mixture of oligomers
12/12/2012CN101786979B (+/-)-marinopyrrole A for resisting methicillin-resistant staphylococcus aureus (MRSA) and synthesized derivative thereof
12/12/2012CN101500994B 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/11/2012US8329934 Isotopically labeled chemically stable reagents and process for the synthesis thereof
12/11/2012US8329921 Metathesis catalyst and process for use thereof
12/11/2012US8329749 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
12/11/2012US8329741 Substituted pyrrolidine compounds with central nervous system activity
12/11/2012US8329377 Imide compound and chemically amplified resist composition containing the same
12/11/2012CA2515780C Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
12/06/2012WO2012167088A1 Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
12/06/2012WO2012166665A2 Broad spectrum antibiotics
12/06/2012WO2012166560A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012WO2012166559A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012WO2012165605A1 Method for producing hemiaminal compound and method for producing cyanoamine compound
12/06/2012WO2012165550A1 Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured article thereof
12/06/2012WO2012165023A1 METHOD FOR PRODUCING OPTICALLY ACTIVE α-SUBSTITUTED PROLINE
12/06/2012WO2012164324A1 Novel processes for the preparation of prostaglandin amides
12/06/2012US20120309985 3-phenoxymethylpyrrolidine compounds
12/06/2012US20120309983 Amino acid group-modified organopolysiloxane and silane, amino acid group-containing compound, and production method thereof
12/06/2012US20120309944 Growth Hormones With Prolonged In-Vivo Efficacy
12/06/2012US20120309938 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/06/2012US20120309795 Heterocyclic inhibitors of necroptosis
12/06/2012US20120308882 Ionic liquid and power storage device including the same
12/06/2012CA2838158A1 Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
12/06/2012CA2837586A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/06/2012CA2837261A1 Novel processes for the preparation of prostaglandin amides
12/06/2012CA2837167A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
12/05/2012EP2528911A2 Compositions and methods for enhancing proteasome activity
12/05/2012CN1893977B Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient.
12/05/2012CN102812003A Pyrrolidine Or Thiazolidine Carboxylic Acid Derivatives, Pharmaceutical Composition And Methods For Use In Treating Metabolic Disordersas As Agonists Of G- Protein Coupled Receptor 43 (GPR43)
12/05/2012CN102807531A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
12/05/2012CN102807520A Ionic liquid and power storage device including the same
12/05/2012CN102807516A Intermediate in amisulpride and method for preparing amisulpride by using intermediate
12/05/2012CN101875625B Recrystallization method for improving trans-fluorochloridone content
12/05/2012CN101684090B Method for preparing amorphous atorvastatin calcium
12/04/2012US8324258 F1F0-ATPase inhibitors and related methods
12/04/2012US8324125 Magnetic nanoparticle-supported glutathione as a sustainable organocatalyst
12/04/2012CA2713025C Kappa selective opioid receptor antagonist
12/04/2012CA2572032C Pesticidal agents on the basis of 1-aryl-aminopyrrol
12/04/2012CA2428834C Biodegradable poly(beta-amino esters) and uses thereof
11/2012
11/29/2012WO2012162416A1 Fatty acid amide hydrolase inhibitors for treating pain
11/29/2012US20120302792 Process of making alpha-aminooxyketone/alpha-aminooxyaldehyde and alpha-hydroxyketone/alpha-hydroxyaldehyde compounds and a process making reaction products from cyclic alpha, beta-unsaturated ketone substrates and nitroso substrates
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012CA2837300A1 Fatty acid amide hydrolase inhibitors for treating pain
11/28/2012EP2527322A1 Carbamyl alkylphenyl disulfide derivatives and their therapeutic uses
11/28/2012EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/28/2012EP2526089A2 A method of industrial production of an amorphous form of atorvastatin with a high specific surface area and its use in a dosage form
11/28/2012EP2526088A1 Intermediates of neutral endopeptidase inhibitors and preparation method thereof
11/28/2012CN1914509B Time-temperature indicator based on valence isomerizations
11/28/2012CN102803257A Insecticidal Compounds
11/28/2012CN102803244A Method Of Synthesizing Organic Molecules
11/28/2012CN102803213A Methyl-substituted TETA Compounds
11/28/2012CN102803212A Heterocyclic Antiviral Compound
11/28/2012CN102803204A Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
11/28/2012CN102796093A Thiomorpholine-containing pyrrole derivatives and their preparation method and use
11/28/2012CN102796036A Preparation method of atorvastatin calcium
11/28/2012CN102060743B Method for preparing N-benzyl-3-pyrrolidone
11/28/2012CN101696183B (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof
11/28/2012CN101667626B Organic electroluminescent devices and metal complex compounds
11/28/2012CN101648891B Aryl cyclobutyl compound and application thereof in preparing weight-losing medicine
11/27/2012US8318760 Type 2 diabetes, atherosclerosis; compounds are N-(2-carboxyethyl)benzamides or N-tetrazolyl derivatives of benzamides; glucagon antagonists
11/27/2012US8318717 Tetrapeptide capable of inhibiting binding of the Smac protein to Inhibitors of apoptosis, thus promoting apoptosis or sensitizing cells; antiproliferative and anticarcinogenic agents
11/27/2012US8318644 Lubricating oil
11/27/2012US8318443 Reagent for detecting an analyte
11/27/2012CA2702482C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2702467C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2531766C Entry inhibitors of the hiv virus
11/22/2012WO2012156400A1 Insecticidal compounds based on arylthioacetamide derivatives
11/22/2012US20120296094 Amide compound or salt thereof, and biofilm inhibitor, biofilm remover and disinfectant containing the same
11/22/2012US20120295910 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists
11/22/2012US20120295874 Coferons and methods of making and using them
11/22/2012US20120294939 Direct compression formulation and process
11/21/2012EP2524911A1 Method for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof
11/21/2012CN102791688A Estrogen receptor ligands
11/21/2012CN102791687A Novel inhibitors of hepatitis C virus replication
11/21/2012CN102786458A Pyrrole formamide derivative, and preparation method and application thereof
11/21/2012CN101906053B 酰胺衍生物 Amide derivatives
11/21/2012CN101903342B Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
11/21/2012CN101892276B Atorvastatin calcium compound and new method thereof
11/21/2012CN101018768B Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
11/20/2012US8314155 Bicyclic aromatic sulfinyl derivatives
11/20/2012US8314140 4-hydroxythiobenzamide derivatives of drugs
11/20/2012US8314139 Toluene sulfonic acid salt of a therapeutic compound and pharmaceutical compositions thereof
11/20/2012CA2608919C Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
11/15/2012WO2012152983A1 Phenyl- sulfonyl derivatives as mediators of trpa1 receptor activity for the treatment of pain
11/15/2012US20120289711 Method for producing carbon nanomaterials and/or carbon micromaterials and corresponding material
11/15/2012US20120289710 Intermediates of neutral endopeptidase inhibitors and preparation method thereof
11/15/2012US20120289576 Process for Forming Amorphous Atorvastatin
11/15/2012US20120289535 Dual phase drug release system
11/15/2012US20120289506 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
11/15/2012US20120289471 Novel compounds with high therapeutic index
11/15/2012CA2835610A1 Proteostasis regulators
11/14/2012EP2522656A2 Process and Intermediate Compounds Useful in the Preparation of Statins, Particularly Atorvastatin
11/14/2012EP2521447A1 Fatty acid fumarate derivatives and their uses
11/14/2012CN102781916A Compounds as bradykinin B1 antagonists
11/14/2012CN102775341A Composition of N-4(anilinophenyl)maleimide and preparation method thereof
11/14/2012CN102775340A Method for synthesizing pyroglutamic calcium glutamate with shells serving as calcium sources
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 404